US

Danny Roland Howard

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Danny Roland Howard: Innovator in Cancer Treatment

Introduction

Danny Roland Howard is a notable inventor in the field of pharmaceuticals, particularly recognized for his contributions to cancer treatment. His innovative work focuses on developing compounds that can enhance the efficacy of immunotherapeutic agents.

Latest Patents

Danny Howard holds a patent for a compound known as 5-Bromo-2,6-Di-(1h-Pyrazol-1-Yl)pyrimidin-4-Amine, which is intended for use in the treatment of cancer. This invention relates to a compound formula that can be used alone or in combination with various immunotherapeutic agents, including anti-CTLA4 antibodies, anti-PD-1 antibodies, and anti-PD-L1 antibodies.

Career Highlights

Throughout his career, Danny has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Palobiofarma S.L. His experience in these organizations has contributed significantly to his expertise in drug development and cancer research.

Collaborations

Danny has collaborated with several professionals in his field, including Sanela Bilic and Juan Alberto Camacho Gomez. These partnerships have fostered a collaborative environment that enhances innovation and research in cancer treatment.

Conclusion

Danny Roland Howard is a dedicated inventor whose work in cancer treatment showcases the potential of innovative compounds in enhancing therapeutic strategies. His contributions to the field are invaluable and reflect a commitment to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…